Heme Oxygenase-1 as a Pharmacological Target for Host-Directed Therapy to Limit Tuberculosis Associated Immunopathology is a research paper published in Antioxidants (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R01 AI134810
NIH HHS
Grant: R01AI134810, R01 AI111940, R21A127182
NIAID NIH HHS
Grant: R01 AI111940
National Institutes of Health
Grant: T32 GM008361
Bill and Melinda Gates Foundation
Grant: OPP1130017
National Institutes of Health
Grant: 5R01AI134810-04
Hydrogen Sulfide and Tuberculosis Disease
National Institutes of Health
Grant: 5R21AI127182-02
Immunometabolism of M. tuberculosis/HIV co-infection
National Institutes of Health
Grant: 5R01AI111940-03
Heme oxygenase-1 and the bioenergetic threshold of latent TB and HIV co-infection
National Institutes of Health
Grant: 5T32GM008361-26
Medical Scientist Training Program
Fields of Study
Keywords
Sustainable Development Goals